Tag Archives: FDA

Marchant on the First Study of Genetics-related Lawsuits

Faculty Director Gary Marchant recently spoke to GenomeWeb about the first empirical study of genetics-related lawsuits, or “genomic malpractice.” The study, conducted by Marchant and Rachel Lindor–a physician and researcher at the Mayo Clinic, was published in the Food and Drug Law Journal earlier … Continue reading

Posted in Announcement, Governance of Emerging Technologies | Tagged , , , , , | Leave a comment

Will Your Next Burger Begin Life in a Lab?

Center Scholar Walter Johnson, along with Faculty Fellow Andrew Maynard and research scientist Sheril Kirshenbaum, recently wrote for The Washington Post about the Impossible Burger, a plant-based food genetically modified to taste like meat. The piece covers recent regulatory discussions about “cultured meat,” including fights with … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment

Talking Regulation at Workshop on Molecular Diagnostics

This article was written by LSI Scholar Walter G. Johnson, class of 2020, who attended the 7th annual Workshop on Regulation and Reimbursement of Molecular Diagnostics. The Center for Law, Science & Innovation (LSI) recently hosted its Workshop on Regulation and … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Tuesday Triple Trivia Tease for March 25, 2014

3 questions. 3 hints. 3 answers. Every Tuesday. 1. What popular expression related to the mind recently made “headlines”?  Was it, a) penny for your thoughts, b) put your thinking cap on, or c) get your brain in gear? Hint: … Continue reading

Posted in Governance of Emerging Technologies, IT & Communications, Public Health Law & Policy | Tagged , , , , , , | Leave a comment

Tuesday Triple Trivia Tease for December 17, 2013

3 questions. 3 hints. 3 answers. Every Tuesday. 1. From genetically modified foods to particular household products, what multi-tasking acronym appears popular with the FDA? Hint: Answer: the FDA has proposed that manufacturers of over-the-counter antibacterial soaps need to establish … Continue reading

Posted in Governance of Emerging Technologies, IT & Communications, Personalized Medicine, Public Health Law & Policy | Tagged , , , , , , , | Leave a comment

23andMeandtheFDA

With the FDA’s warning letter to 23andMe and follow-up articles taking news networks by storm, ASU law professor, Gary Marchant weighed in on the issue in an article for Slate entitled The FDA Could Set Personal Genetics Rights Back Decades.  In his … Continue reading

Posted in Governance of Emerging Technologies, Personalized Medicine, Public Health Law & Policy | Tagged , , , | Leave a comment

The Spurned Salmon

Despite the fact that GM salmon would reduce over-fishing of wild salmon populations and enhance our food supply, anti-GM activists are going after retailers in an attempt to stop them from selling the genetically-altered fish.  After having established that it is as safe … Continue reading

Posted in Governance of Emerging Technologies, Public Health Law & Policy | Tagged , | Leave a comment